Drug maker Lupin on Thursday said it has opened its first laboratory in East India in Kolkata.
The new reference laboratory at Kolkata has capabilities to conduct a broad spectrum of routine and specialized tests in the fields of molecular diagnostics, cytogenetics, flow cytometry, histopathology, cytology, microbiology, serology, haematology, immunology and routine
biochemistry.
The Kolkata reference laboratory will act as the hub for Lupin's development plans in East India, where it is also setting up processing laboratories in West Bengal Assam,Bihar,Jharkhandand Orissa to cater to a market that is often overlooked
by large diagnostic chains.
These processing labs will be situated in the cities of Siliguri, Berhampore, Asansol, Burdwan and Bankura in West Bengal, along with Guwahati (Assam), Patna (Bihar), Ranchi and Dhanbad (Jharkhand) and Bhubaneshwar (Orissa).
These labs will be linked to Lupin’s franchise collection centers, LupiMitra.
Lupin Diagnostics has more than 100 LupiMitra already enrolled for its East India operations.
The firm offers a comprehensive range of diagnostics services to doctors, patients and consumers. Some of its key consumer-centric features are GPS-enabled temperature–controlled sample movement, smart reports, NABL accreditation of each laboratory, trend report analysis, and live home collection booking and tracking.
Lupin launched diagnostic operations in December with 11 labs including a 45,000 square feet national reference lab in Navi Mumbai and 200 collection centres.
The drug maker said it strategy to open over 100 labs across and 1000 collection centres across India in the next three years.
About 90% of collection centres will be run by franchisees.
.jpg "Technology in Cancer Care: A story of evolving paradigms")
.jpg "Bringing Shop Floor to Manufacturer's palm: Smart Factory Solutions for tomorrow")
